Business

Johnson & Johnson vaccine production restarts in Baltimore but still not authorized for distribution

Read more at www.washingtonpost.com

Emergent BioSolutions said Thursday it has received the go-ahead from the Food and Drug Administration to resume manufacturing Johnson & Johnson coronavirus vaccine after a suspension of more than 100 days because of cross-contamination at its …

Read more at www.washingtonpost.com

Show More

Related Articles

Back to top button